<?xml version="1.0" encoding="UTF-8"?>
<title-group>
 <article-title>Theoretical risk of genetic reassortment should not impede development of live, attenuated Rift Valley fever (RVF) vaccines commentary on the draft WHO RVF Target Product Profile</article-title>
</title-group>
